Reuters - Deals Today

Click to View in Browser

Monday, January 8, 2018

Novo Nordisk bids $3.1 billion for Belgian biotech group Ablynx

BRUSSELS (Reuters) - Denmark's Novo Nordisk , the world's biggest maker of insulin, has made a 2.6 billion euro ($3.1 billion) bid for Belgian biotech group Ablynx as it seeks to diversify and strengthen its business for treating rare blood disorders.

U.S. oilfield service firms dust off IPO plans as crude prices surge

HOUSTON (Reuters) - U.S. oilfield service companies are gearing up for initial public offerings, according to regulatory filings and analysts, after several shelved equity sales last year during a weak period for oil prices.

Fresenius CFO backs acquisition course: Boersen-Zeitung

FRANKFURT (Reuters) - German healthcare group Fresenius will continue to look for acquisitions even if that leads to a temporary rise in debt, Boersen-Zeitung quoted the company's finance chief as saying.

TP ICAP buys U.S. energy and commodities broker SCS

(Reuters) - TP ICAP Plc , the world's largest interdealer broker, said it had bought SCS Commodities Corp, a U.S. energy and commodities broker for an undisclosed sum.

Siemens to list Healthineers unit in March: sources

MUNICH (Reuters) - Siemens is planning to list its 40 billion euro ($47.94 billion) healthcare unit Healthineers in March, two people close to the matter said, as the group hopes to execute the deal while market conditions are favourable.

Exclusive: Kuwait Energy in merger talks with London-listed SOCO International - sources

DUBAI (Reuters) - Oil and gas firm Kuwait Energy is in talks to merge with SOCO International , an oil and gas exploration and production company listed on the London Stock Exchange, two sources familiar with the matter said.

Novo Nordisk's $3.1 billion Ablynx bid rejected by Belgian biotech

COPENHAGEN/BRUSSELS (Reuters) - Denmark's Novo Nordisk, the world's biggest maker of insulin, went public with a 2.6 billion euro ($3.1 billion) bid for Belgian biotech group Ablynx on Monday as it seeks to bolster its treatments for rare blood disorders.

Celgene to buy Impact Biomedicines for up to $7 billion

NEW YORK (Reuters) - U.S. biotech pharmaceutical firm Celgene Corp said on Sunday that it had agreed to acquire Impact Biomedicines for as much as $7 billion, subject to certain milestones associated with regulatory hurdles and sales performance.

Three investors place bids for Germany's HSH Nordbank - source

BERLIN (Reuters) - Three private-equity investors have submitted bids for German state-backed HSH Nordbank [HSH.UL], a person familiar with the matter said, as the EU-enforced privatization of the lender is nearing the finishing line.

China's FAW Car buys 10 percent stake in Mobike's new car-sharing unit

BEIJING (Reuters) - FAW Car Co Ltd said on Sunday it was taking a 10 percent stake in Chinese bicycle-sharing startup Mobike's new car-sharing unit Mobike Chuxing Technology Co.